










Radiation therapy




Stem cell transplant





Newer treatments

Doctors are studying a newer form of radiation therapy that may help control high-risk neuroblastoma. The treatment uses a radioactive form of the chemical metaiodobenzylguanidine (MIBG). When injected in to the bloodstream, the MIBG travels to the neuroblastoma cells and releases the radiation.

MIBG therapy is sometimes combined with chemotherapy or stem cell transplant. After receiving an injection of the radioactive MIBG, your child will need to stay in a special hospital room until the radiation leaves his or her body in the urine. MIBG therapy usually takes a few days.

Dec. 04, 2015
  1. Kliegman RM, et al. Neuroblastoma. In: Nelson Textbook of Pediatrics. 20th ed. Philadelphia, Pa.: Elsevier; 2016. Accessed Nov. 3, 2015.
  2. Irwin MS, et al. Neuroblastoma: Paradigm for precision medicine. Pediatric Clinics of North America. 2015;62:225.
  3. Niederhuber JE, et al., eds. Pediatric solid tumors. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. Accessed Nov. 3, 2015.
  4. Neuroblastoma treatment (PDQ). National Cancer Institute. Accessed Nov. 3, 2015.
  5. Wilson JS, et al. A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma. European Journal of Cancer. 2014;50:801.
  6. Radiation therapy for neuroblastoma. American Cancer Society. Accessed Nov. 11, 2015.